uniQure (NASDAQ:QURE) Rating Increased to Outperform at Royal Bank Of Canada

Royal Bank of Canada upgraded uniQure to outperform, raising price target from $11 to $35. Similarly, it reaffirmed outperform for Doximity, setting a $44 target. Both moves reflect bullish outlooks from the bank. The bank’s research teams highlighted growth potential in both companies’ sectors, noting favorable market dynamics and product pipelines.